NEO News and Press, NeoGenomics Inc. From 04/09/24

NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced that it will report its first quarter 2024 financial results on Tuesday, April 30, 2024. Company management will host a webcast and conference call that morning at 8:30 a.m. Eastern Time to discuss fin...

2024-04-03 12:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-03-31 07:38:40 ET Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Spotify . Read the full article on Seeking Alpha For further details see: Wall Street Breakfast: The Week Ahead

2024-03-28 15:00:00 ET More on the markets Where This Market Is Going (Technical Analysis) SPY: 2 Opposing Forces Wall Street Lunch: Fed Not Spooked By Recent Inflation Overbought conditions flash across all market caps: Bespoke Investment Group Energ...

Insights from 11 Abstracts Highlight Key Findings Across the Oncology Care Spectrum NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, alongside research collaborators, will present key findings from 11 abstracts at the American Association for Cancer Re...

NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today released its 2023 Environmental, Social, and Governance (ESG) Report highlighting progress toward building a more sustainable, diverse, and equitable company that delivers exceptional customer experience and...

2024-03-18 15:30:02 ET Piper Sandler analyst issues BUY recommendation for NEO on March 18, 2024 02:00PM ET. The previous analyst recommendation was Buy. NEO was trading at $14.76 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current an...

2024-03-14 09:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced the company will participate in the upcoming TD Cowen 44th Annual Health Care Conference in Boston, Massachusetts. Members of NeoGenomics’ management team will participate in a fireside chat...

2024-02-21 10:06:26 ET NeoGenomics ( NASDAQ: NEO ) shares rose over 9% in morning trading on Wednesday after the cancer diagnostics firm forecast annual revenue above Wall Street estimates.... Read the full article on Seeking Alpha For further details see: NeoGenomic...